A couple in their late forties came in for what they thought was going to be a hormone consultation for her. Halfway through the visit, it became clear that the actual reason they had driven from Phenix City was that the physical part of their marriage had quietly fallen apart over the previous three years and neither of them knew how to bring it up with a clinician. She had been told her labs were "normal." He had been started on an SSRI for sleep that was probably contributing. Nobody had ever asked them, in a single visit, what was actually happening between them and what the physiology might be doing to make it harder.
That visit is more typical than people realize. When I evaluate someone — or a couple — for what they describe as a loss of intimacy in mid-life, the most useful thing I can do is treat it as a clinical problem with multiple inputs, because that is almost always what it is. The under-discussion of this issue in standard medicine is a real failure, and the patients who pay the price are the ones who assumed nobody could help.
Why this is so often missed
Intimacy in mid-life sits at the intersection of several systems that primary care does not routinely evaluate together. Sex hormones decline. Vascular function changes. Sleep architecture shifts. Stress and load increase. Medications accumulate. Body changes affect self-perception. Relationship dynamics evolve. Any one of these can be the dominant driver in a given patient, and most patients have two or three operating at once.
The patient who walks in describing low libido is not lying when she says she is "just not interested." She is reporting an outcome — but the outcome has inputs, and the inputs are usually treatable. I see this constantly: a woman whose libido vanished in perimenopause assumes it is psychological because that is the framing she has been given. The labs tell a different story. A man whose erections have weakened over five years assumes it is just age. His free testosterone is 280 and his fasting insulin is 18. There is mechanism here, not just inevitability.
The studies put numbers on it: 40 to 60 percent of women experience some form of sexual dysfunction in perimenopause and menopause, and 30 to 50 percent of men experience it by age 50. None of that is "just stress."
What I actually look for in the workup
When a patient comes in for what I will broadly call a sexual wellness evaluation, I run through a structured set of inputs.
Hormonal. For women: estradiol, progesterone, total and free testosterone, DHEA-S, SHBG, FSH, LH. Free testosterone in women is the marker most likely to surprise patients — values under 1.0 pg/mL are common in patients reporting low libido and low arousal, and replacement is often life-changing. For men: total and free testosterone, estradiol, SHBG, prolactin, LH, FSH, and PSA. Free testosterone under about 100 pg/mL in a symptomatic man is rarely incidental.
Vascular. Blood pressure, lipid panel, fasting glucose and insulin, HbA1c. Erectile dysfunction is often the earliest visible sign of vascular disease — the penile arteries are smaller than the coronaries, so they show endothelial dysfunction first. A man presenting with new ED in his forties is also a man whose cardiovascular risk needs to be characterized, not just his testosterone.
Thyroid. TSH, free T3, free T4, reverse T3, antibodies. Subclinical hypothyroidism is a frequent occult driver of low libido in both sexes.
Medications. SSRIs and SNRIs are notorious. Beta-blockers reduce libido and erectile function. Antihistamines (especially the sedating ones) impair arousal. PPIs interfere with several relevant pathways. Statins occasionally contribute. Birth control pills suppress free testosterone in women through SHBG elevation in ways that persist after discontinuation. I review the full medication list, including over-the-counter, every visit.
Sleep. Sleep apnea suppresses testosterone. Fragmented sleep flattens the cortisol curve and impairs morning arousal. If the bed-partner says you snore, it matters here.
Tissue and pelvic-floor health. For women: vaginal atrophy, dryness, pain with intercourse. For men: penile sensitivity changes, foreskin or skin sensitivity, pelvic-floor tension.
Psychological and relational context. Without prying, I ask whether the change in physiology happened first or whether the relationship distance happened first. The order matters for the treatment plan.
The mechanism of arousal — why a single fix often does not work
Arousal is not a single switch. In both sexes, it requires a permissive hormonal background, intact vascular response, intact neurological signaling, an adequate sleep and stress state, and a context that is not actively suppressing it. If any one of those is significantly off, the rest of the system underperforms even when the others are intact.
In women, estradiol maintains vaginal tissue integrity, vascular responsiveness, and neurological sensitivity. Progesterone supports calm and sleep — both of which gate desire. Testosterone drives libido, motivation, and the central reward response to sexual cues. DHEA contributes to local tissue conversion of androgens. Take any one of these out of optimal range and the system gets less responsive.
In men, free testosterone drives libido and morning erections. Estradiol — yes, estradiol in men — maintains erectile function and libido at appropriate levels (too low is as much a problem as too high). Adequate vascular endothelial function is required for the actual erection to happen. Adequate sleep produces the testosterone in the first place; testosterone is mostly secreted during deep sleep.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
This is why a single intervention — a Viagra prescription, a testosterone shot, a couples weekend — frequently disappoints. The system has multiple inputs and the plan needs to address multiple inputs.
How treatment actually gets built
Once the workup is in, the treatment plan addresses the dominant drivers in priority order.
Hormonal restoration. Hormone optimization for women in the appropriate range — estradiol, progesterone, sometimes testosterone — restores the permissive background that everything else depends on. Men's hormone therapy for testosterone-deficient men typically restores morning erections and libido within four to eight weeks if there are no other significant contributors.
Vascular and metabolic work. If the workup showed insulin resistance, untreated hypertension, or a poor lipid picture, those get addressed in parallel. A man with ED and a fasting insulin of 22 is not going to fully respond to testosterone alone; the metabolic piece has to move too.
Direct tissue work. This is where regenerative procedures fit. The O-Shot — PRP injection into specific areas of the vaginal and clitoral tissue — improves local tissue quality, sensitivity, and arousal in appropriately selected women, particularly those with tissue changes from perimenopause, post-childbirth changes, or post-cancer treatment. The P-Shot is the corresponding procedure for men. PRP is not a substitute for hormone optimization — it works best as the tissue-level layer on top of a corrected hormonal background.
ED-specific intervention. For men, ED treatment options include the standard PDE5 inhibitors, regenerative approaches, and increasingly shockwave-based options. The choice depends on whether the issue is primarily vascular, primarily neurological, or primarily hormonal — which is what the workup tells us.
Medication adjustment. Sometimes the most useful thing I do is coordinate with the prescribing physician to adjust an SSRI to something less sexually suppressive, or to time a beta-blocker differently, or to wean a sedating antihistamine that did not need to be daily.
Pelvic floor and behavioral. For some patients — particularly women with post-childbirth or post-menopausal pelvic-floor changes — pelvic floor PT is the right next step alongside hormonal work.
How I evaluate who is a candidate for what
Not every patient needs every tool. The candidacy logic I use:
Hormone optimization is the right first move when labs confirm hormonal contribution and there are no specific contraindications (active hormone-sensitive cancer, recent thrombotic event, certain pregnancy considerations).
The O-Shot or P-Shot is appropriate when there is a tissue-quality or local sensitivity component, the patient is on a corrected hormonal background or being moved toward one in parallel, and there are no contraindications to PRP. It is not appropriate as a first-line solo intervention in a patient with a frank hormonal deficit — fixing the hormone first changes the response to the procedure.
ED-specific interventions are layered based on what the vascular and hormonal workup showed. A patient whose ED is primarily vascular needs the cardiovascular workup pursued; a stent-eligible coronary lesion is not something to discover after I have started him on testosterone.
Couples-level work is appropriate when the relational distance is the dominant driver and the physiology is largely intact. I will say so when that is what I see, and refer to the right professional for that work.
A concrete next step
If intimacy is the reason you have been thinking about a visit and you have been holding off, the most useful first step is a private consultation. The conversation is private. The clinical room has time blocked for it — these are not rushed visits. We talk through what is happening, what you have already tried, what is on your medication list, and what your goals are. Then we order the labs that actually match the picture, and the second visit is the plan with the data in hand.
If you are coming as a couple, book one extended consultation and tell the front desk it is a couple's visit so the time gets blocked appropriately. The Columbus consultation and the Warner Robins consultation use the same protocol, and either location can accommodate this.
The patients who do best in this work are the ones who decided not to wait until the issue had quietly cost them another two or three years. If that is where you are, the appointment is the first move.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.